echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Ministry of Commerce: Cultivate 5-10 50 billion pharmacies within 5 years

    Ministry of Commerce: Cultivate 5-10 50 billion pharmacies within 5 years

    • Last Update: 2021-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Ministry of Commerce issued a document to cultivate 5-10 giant pharmacies with annual sales of 50 billion yuan by 2025


    Ministry of Commerce issued a document to cultivate 5-10 50 billion pharmacies

    Ministry of Commerce issued a document to cultivate 5-10 50 billion pharmacies

    On October 28, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-Quality Development of the Pharmaceutical Circulation Industry during the "14th Five-Year Plan" Period" (hereinafter referred to as the "Opinions")


    According to the target plan of the "Opinions", by 2025, the pharmaceutical distribution industry will meet the needs of people's health in the new stage of development in China, and the modern pharmaceutical distribution system featuring innovation, technology empowerment, coverage of urban and rural areas, balanced layout, coordinated development, and safety and convenience will be more complete.


    At the same time, cultivate 1-3 large-scale digital and comprehensive drug distribution companies with a value of more than 500 billion yuan, 5-10 with a value of more than 100 billion yuan, and 5-10 specialized and diversified drug retail chains with a value of more than 50 billion yuan.


    By 2025, the annual sales of the top 100 pharmaceutical wholesale companies will account for more than 98% of the total pharmaceutical wholesale market; the annual sales of the top 100 pharmaceutical retail companies will account for more than 65% of the total pharmaceutical retail market; and the drug retail chain rate will be close to 70%


    Optimize the layout and encourage the characteristic development of pharmacies

    Optimize the layout and encourage the characteristic development of pharmacies

    At the same time, the "Opinions" also talked about the need to improve the function of urban and rural drug distribution and focus on improving the level of drug distribution


    In terms of improving the circulation function of urban and rural medicines, the "Opinions" require three points:

    First, optimize the industry layout


    Second, speed up the construction of rural drug distribution networks


    Third, improve the city's drug circulation service capabilities


    In terms of improving the energy level of drug circulation, two things must be done:

    One is to develop modern pharmaceutical logistics


    The second is to develop a modern green smart supply chain


    Three development directions, retail pharmacies are well received

    Three development directions, retail pharmacies are well received

    In addition, the "Opinions" also provides three directions for the development of retail pharmacies:

    First, steadily develop digital drug circulation

    Promote the "Internet + drug circulation": accelerate the application of 5G networks, big data and other technologies, optimize the traditional mode of drug circulation, and achieve iterative upgrades of elements, structures, processes, and services


    Develop new business formats and new models: support the integrated development of pharmaceutical distribution companies and e-commerce platforms, develop smart supply chains, smart logistics, smart pharmacies, and other new forms, promote new retail models such as "online order-in stores" and "online-order stores delivery", and guide Online and offline standardized development


    Second, continue to optimize the structure of the circulation industry

    Cultivate and strengthen the circulation main body: support the cross-regional and cross-ownership merger and reorganization of drug circulation enterprises, and cultivate large-scale modern drug circulation backbone enterprises


    Third, promote foreign exchanges and cooperation

    Actively carry out international exchanges and cooperation: Promote pharmaceutical distribution companies to face both international and domestic markets, and carry out various forms of international exchanges and investment cooperation


    Vigorously develop the foreign trade of Chinese medicine: support the overseas registration of Chinese medicine products, actively participate in the research and formulation of international plans and standards, and expand the scale of the international market for Chinese medicine products


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.